University of Colorado Denver-ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2021

  1. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

    The Lancet Neurology, Vol. 20, Núm. 1, pp. 49-59

2020

  1. Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis

    Frontiers in Pediatrics, Vol. 8

2019

  1. Wavefront Field Mapping Reveals a Physiologic Network Between Drivers Where Ablation Terminates Atrial Fibrillation

    Circulation: Arrhythmia and Electrophysiology, Vol. 12, Núm. 8

2018

  1. Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

    European Journal of Cancer, Vol. 100, pp. 35-45

2017

  1. Lung cancer: current therapies and new targeted treatments

    The Lancet, Vol. 389, Núm. 10066, pp. 299-311

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients

    Journal of Clinical Immunology, Vol. 35, Núm. 2, pp. 189-198

2012

  1. Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise

    Arthritis Care and Research, Vol. 64, Núm. 3, pp. 351-357

2009

  1. Pulmonary zygomycosis in solid organ transplant recipients in the current era

    American Journal of Transplantation, Vol. 9, Núm. 9, pp. 2166-2171

  2. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome

    Journal of Infectious Diseases, Vol. 200, Núm. 6, pp. 1002-1011

2003

  1. Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C

    Gut, Vol. 52, Núm. 3, pp. 425-432

1998

  1. Elevated levels of interferon gamma, tumor necrosis factor alpha, interleukins 2, 4, and 5, but not interleukin 10, are present in recurrent aphthous stomatitis

    ARCHIVES OF DERMATOLOGY

  2. The enamel paint sign in the dermatologic diagnosis of early-onset kwashiorkor

    ARCHIVES OF DERMATOLOGY